M P Fink Selected Research

M P Fink Research Topics

6	Sepsis (Septicemia) 05/2004 - 05/2000
5	Ischemia 10/2006 - 09/2000
3	Septic Shock (Toxic Shock Syndrome) 08/2001 - 04/2000
3	Hypoxia (Hypoxemia) 04/2001 - 04/2000
2	Shock 05/2004 - 04/2000
2	Mesenteric Ischemia 08/2001 - 04/2001
2	Critical Illness (Critically Ill) 04/2001 - 04/2000
2	Hemorrhagic Shock 04/2001 - 05/2000
1	Arthritis (Polyarthritis) 10/2010
1	Inflammation (Inflammations) 04/2007
1	Reperfusion Injury 10/2006
1	Endotoxemia 05/2004
1	Pathologic Processes 04/2001
1	Cardiomyopathies (Cardiomyopathy) 04/2001
1	Multiple Organ Failure (MODS) 09/2000
1	Thoracoabdominal Aortic Aneurysm 09/2000
1	Heart Diseases (Heart Disease) 06/2000
1	Hemorrhage 05/2000

4	SolutionsIBA 10/2006 - 04/2001
3	ethyl pyruvateIBA 10/2010 - 08/2001
3	Pyruvic Acid (Pyruvate)IBA 04/2007 - 08/2001
3	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2004 - 04/2001
2	EstersIBA 10/2010 - 04/2007
2	Ringer's ethyl pyruvateIBA 08/2001 - 04/2001
2	Hemoglobins (Hemoglobin)IBA 08/2001 - 06/2000
2	Adenosine Diphosphate (ADP)IBA 04/2001 - 05/2000
2	EnzymesIBA 04/2001 - 05/2000
2	CytokinesIBA 09/2000 - 04/2000
1	Freund's AdjuvantIBA 10/2010
1	EmulsionsIBA 10/2010
1	Collagen Type II (Type II Collagen)IBA 10/2010
1	AnionsIBA 04/2007
1	Carbon MonoxideIBA 10/2006
1	ProstaglandinsIBA 09/2001
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2001
1	Ringer's LactateIBA 08/2001
1	Mucin-6IBA 08/2001
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 08/2001
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2001
1	Adenosine Triphosphate (ATP)IBA 04/2001
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2001
1	Adenosine (Adenocard)FDA LinkGeneric 10/2000
1	Adenosine DeaminaseIBA 10/2000
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 05/2000
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2000
1	lisofyllineIBA 05/2000
1	Peroxynitrous Acid (Peroxynitrite)IBA 05/2000
1	Oxygen (Dioxygen)IBA 04/2000